27.08.2018 | News
Berlin, Germany — August 27, 2018 — SOMATEX® Medical Technologies GmbH announced today the launch of its new Tumark Eye, an innovative clip marking system for breast cancer, featuring a highly distinctive shape and excellent ultrasound visibility.
“With the new Tumark Eye marker, we are expanding our biopsy clip portfolio to offer even more diagnostic options in breast care. We focus on providing solutions with excellent ultrasound visibility and no marker dislocation rate.“ commented Joerg Heise, Managing Director of SOMATEX.
The unique “eye” shape is outstanding for marking and independently identifying biopsy sites in the breast. Furthermore, the system helps doctors to pinpoint markings in the soft tissue before or during a neoadjuvant chemotherapy.
Priority Medical is exclusively launching Tumark Eye in the U.S. “We are committed to offering advanced solutions for patients and doctors. SOMATEX continually bring better diagnostics and
improve the standard of care. The Tumark Eye is going to revolutionize the market.“
said Terry Dougherty, Managing Director of Priority Medical.
About SOMATEX® Medical Technologies GmbH
SOMATEX® Medical Technologies GmbH specializes in the development and manufacturing of minimally invasive devices in the areas of tumor diagnostics, biopsy and assisted reproduction. The company’s core expertise lies in the development of new innovations and solutions tailored to the needs of medical professionals and patients.
For more information visit: www.somatex.com
+49 30 319 8225-00